Naphthalimides Selectively Inhibit the Activity of Bacterial, Replicative DNA Ligases and Display Bactericidal Effects against Tubercle Bacilli-Reference-Cited by-同舟云学术

Naphthalimides Selectively Inhibit the Activity of Bacterial, Replicative DNA Ligases and Display Bactericidal Effects against Tubercle Bacilli

Published:2017-01-17 Issue:1 Volume:22 Page:154
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Korycka-Machala Malgorzata,Nowosielski Marcin,Kuron Aneta,Rykowski Sebastian,Olejniczak Agnieszka,Hoffmann Marcin,Dziadek Jaroslaw

Funder

National Science Centre, Poland

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/22/1/154/pdf

Reference51 articles.

1. Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria

2. WHO Global Tuberculosis Report 2015,2015

3. WHO Drug-Resistant TB-Surveillance and Response,2015

4. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review

5. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluorescent Polymers for Environmental Monitoring: Targeting Pathogens and Metal Contaminants with Naphthalimide Derivatives;2024

2. Drug Discovery for Mycobacterium tuberculosis Using Structure-Based Computer-Aided Drug Design Approach;International Journal of Molecular Sciences;2021-12-09

3. Hybridization Approach to Drug Discovery Inhibiting Mycobacterium tuberculosis-An Overview;Current Topics in Medicinal Chemistry;2021-05-26

4. Structure based identification of first-in-class fragment inhibitors that target the NMN pocket of M. tuberculosis NAD+-dependent DNA ligase A;Journal of Structural Biology;2021-03

5. Early Drug Development and Evaluation of Putative Antitubercular Compounds in the -Omics Era;Frontiers in Microbiology;2021-02-02